Clinical trial condition

NSCLC

Explore clinical trials studying NSCLC. Study availability and eligibility vary by location and protocol.

367 public trials 125 recruiting studies

Refine in advanced search Browse all conditions

NSCLC trial results

Active, not recruiting

A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With NSCLC

NCT05756972

Conditions: NSCLC
Locations: Medical Ethics Committee of Guangdong Provincial People's Hospital Guangzhou, Guangdonng, China

View Trial Details

Active, not recruiting

Study to Evaluate D-1553 in Subjects With Solid Tumors

NCT04585035

Conditions: CRC, NSCLC, Solid Tumor, Adult
Locations: Research Site Fresno, California, United States

Research Site Orange, California, United States

Research Site San Francisco, California, United States

Research Site Louisville, Kentucky, United States

View all 25 locations

View Trial Details

Active, not recruiting

Korean Registry of Non-Small Cell Lung Cancer Patients with EGFR Mutation

NCT06247280

Conditions: NSCLC
Locations: Kyungpook National University Chilgok Hospital Chilgok, Daegu, South Korea

Hallym Univ. Medical Center. Chuncheon Chuncheon, Gangwon-do, South Korea

Wonju Severance Christian Hospital Wŏnju, Gangwon-do, South Korea

Soon Chun Hyang University Hospital Bucheon Bucheon-si, Gyeonggi-do, South Korea

View all 39 locations

View Trial Details

Active, not recruiting

A Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients

NCT03866499

Conditions: NSCLC
Locations: Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China

Linyi Cancer Hospital Linyi, Shandong, China

View Trial Details

Active, not recruiting

Durvalumab(MEDI4736) After chemoRadioTherapy(DART) for NSCLC-a Translational and Biomarker Study

NCT04392505

Conditions: Bronchial Neoplasms, Cancer, Carcinoma, Bronchogenic, +12 more
Locations: North Estonia Medical Centre Tallinn, Estonia

Oulu University Hospital Oulu, Finland

Tampere University Hospital Tampere, Finland

Turku University Hospital Turku, Finland

View Trial Details

Completed

Pixatimod (PG545) Plus Nivolumab in PD-1 Relapsed/Refractory Metastatic Melanoma and NSCLC and With Nivolumab and Low-dose Cyclophosphamide in MSS Metastatic Colorectal Carcinoma (mCRC)

NCT05061017

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +21 more
Locations: UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Afatinib in NSCLC With HER2 Mutation

NCT02369484

Conditions: NSCLC
Locations: Universitätsklinikum Köln Cologne, Germany

NKI-AVL Amsterdam, Netherlands

Vall d'Hebron University Hospital Barcelona, Spain

CHUV Lausanne, Switzerland

View Trial Details

Completed

Study of FURMONERTINIB in Patients With NSCLC Having Exon 20 Insertion Mutation

NCT04858958

Conditions: NSCLC
Locations: Shanghai Chest hospital Shanghai, China

View Trial Details

Completed

Epidemiology of Young Lung Cancer - Survey

NCT04640259

Conditions: NSCLC
Locations: USC Keck School of Medicine Los Angeles, California, United States

Addario Lung Cancer Medical Institute San Carlos, California, United States

View Trial Details

Completed

A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors

NCT06403436

Conditions: Adult Disease, Adult Solid Tumor, Advanced Solid Tumor, +9 more
Locations: Sarah Cannon Research Institute Oncology Partners Nashville, Tennessee, United States

NEXT Oncology Virginia Fairfax, Virginia, United States

NEXT Oncology Barcelona Barcelona, Spain

Vall d'Hebron Institute of Oncology Barcelona, Spain

View Trial Details

NSCLC

NSCLC trial results

Related conditions